Ashley Elizabeth Schneider, MD | |
10330 Hickman Mills Dr, Kansas City, MO 64137-1618 | |
(816) 412-7004 | |
Not Available |
Full Name | Ashley Elizabeth Schneider |
---|---|
Gender | Female |
Speciality | Pathology |
Experience | 15 Years |
Location | 10330 Hickman Mills Dr, Kansas City, Missouri |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1245468909 | NPI | - | NPPES |
201099800A | Medicaid | KS | |
6040 | Other | NE | TEMPORARY EDUCATIONAL PERMIT |
Facility Name | Location | Facility Type |
---|---|---|
Saint Luke's South Hospital | Overland park, KS | Hospital |
St Lukes Hospital Of Kansas City | Kansas city, MO | Hospital |
Saint Luke's East Hospital | Lees summit, MO | Hospital |
Saint Lukes North Hospital | Kansas city, MO | Hospital |
Adventhealth Shawnee Mission | Shawnee mission, KS | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Mawd Pathology Group Pa | 2668421389 | 38 |
Mawd Pathology Group Pa | 2668421389 | 38 |
News Archive
Researchers at Children's Hospital Los Angeles have demonstrated that adolescents and young adults with congenital adrenal hyperplasia (CAH) have significantly increased amounts of abdominal fat tissue, placing them at greater risk for harmful conditions linked to obesity, including cardiovascular disease (CVD).
Initial, independent review of study data from the Selenium and Vitamin E Cancer Prevention Trial (SELECT), funded by the National Cancer Institute (NCI) and other institutes that comprise the National Institutes of Health shows that selenium and vitamin E supplements, taken either alone or together, did not prevent prostate cancer.
PDL BioPharma, Inc. today announced that it has entered into a revenue interest assignment agreement (the "Agreement") in which it has agreed to provide ARIAD Pharmaceuticals, Inc. with up to $200 million in revenue interest financing in exchange for royalties on the net revenues of Iclusig (ponatinib).
The American Society of Plastic Surgeons today announced its strong support of the "Breast Cancer Patient Education Act" (S. 931). This bipartisan legislation is being introduced today, coinciding with National Women's Health Week, in the U.S. House of Representatives by Reps. Leonard Lance (R-NJ) and Donna Christensen, M.D. (D-VI) and in the United States Senate by Sens. Roy Blunt (R-MO), Sherrod Brown (D-OH) and David Vitter (R-LA).
"A bitter Congressional fight over the cost of superexpensive biotechnology drugs has come down to a single, hotly debated number: How many years should makers of those drugs be exempt from generic competition?" The New York Times reports.
› Verified 3 days ago
Entity Name | Mawd Pathology Group Pa |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1033108519 PECOS PAC ID: 2668421389 Enrollment ID: O20061024000121 |
News Archive
Researchers at Children's Hospital Los Angeles have demonstrated that adolescents and young adults with congenital adrenal hyperplasia (CAH) have significantly increased amounts of abdominal fat tissue, placing them at greater risk for harmful conditions linked to obesity, including cardiovascular disease (CVD).
Initial, independent review of study data from the Selenium and Vitamin E Cancer Prevention Trial (SELECT), funded by the National Cancer Institute (NCI) and other institutes that comprise the National Institutes of Health shows that selenium and vitamin E supplements, taken either alone or together, did not prevent prostate cancer.
PDL BioPharma, Inc. today announced that it has entered into a revenue interest assignment agreement (the "Agreement") in which it has agreed to provide ARIAD Pharmaceuticals, Inc. with up to $200 million in revenue interest financing in exchange for royalties on the net revenues of Iclusig (ponatinib).
The American Society of Plastic Surgeons today announced its strong support of the "Breast Cancer Patient Education Act" (S. 931). This bipartisan legislation is being introduced today, coinciding with National Women's Health Week, in the U.S. House of Representatives by Reps. Leonard Lance (R-NJ) and Donna Christensen, M.D. (D-VI) and in the United States Senate by Sens. Roy Blunt (R-MO), Sherrod Brown (D-OH) and David Vitter (R-LA).
"A bitter Congressional fight over the cost of superexpensive biotechnology drugs has come down to a single, hotly debated number: How many years should makers of those drugs be exempt from generic competition?" The New York Times reports.
› Verified 3 days ago
Entity Name | Mawd Pathology Partners Pa |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1508249228 PECOS PAC ID: 7618278771 Enrollment ID: O20151214001703 |
News Archive
Researchers at Children's Hospital Los Angeles have demonstrated that adolescents and young adults with congenital adrenal hyperplasia (CAH) have significantly increased amounts of abdominal fat tissue, placing them at greater risk for harmful conditions linked to obesity, including cardiovascular disease (CVD).
Initial, independent review of study data from the Selenium and Vitamin E Cancer Prevention Trial (SELECT), funded by the National Cancer Institute (NCI) and other institutes that comprise the National Institutes of Health shows that selenium and vitamin E supplements, taken either alone or together, did not prevent prostate cancer.
PDL BioPharma, Inc. today announced that it has entered into a revenue interest assignment agreement (the "Agreement") in which it has agreed to provide ARIAD Pharmaceuticals, Inc. with up to $200 million in revenue interest financing in exchange for royalties on the net revenues of Iclusig (ponatinib).
The American Society of Plastic Surgeons today announced its strong support of the "Breast Cancer Patient Education Act" (S. 931). This bipartisan legislation is being introduced today, coinciding with National Women's Health Week, in the U.S. House of Representatives by Reps. Leonard Lance (R-NJ) and Donna Christensen, M.D. (D-VI) and in the United States Senate by Sens. Roy Blunt (R-MO), Sherrod Brown (D-OH) and David Vitter (R-LA).
"A bitter Congressional fight over the cost of superexpensive biotechnology drugs has come down to a single, hotly debated number: How many years should makers of those drugs be exempt from generic competition?" The New York Times reports.
› Verified 3 days ago
Entity Name | Mawd Pathologists, Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1376209130 PECOS PAC ID: 5193102028 Enrollment ID: O20220517002528 |
News Archive
Researchers at Children's Hospital Los Angeles have demonstrated that adolescents and young adults with congenital adrenal hyperplasia (CAH) have significantly increased amounts of abdominal fat tissue, placing them at greater risk for harmful conditions linked to obesity, including cardiovascular disease (CVD).
Initial, independent review of study data from the Selenium and Vitamin E Cancer Prevention Trial (SELECT), funded by the National Cancer Institute (NCI) and other institutes that comprise the National Institutes of Health shows that selenium and vitamin E supplements, taken either alone or together, did not prevent prostate cancer.
PDL BioPharma, Inc. today announced that it has entered into a revenue interest assignment agreement (the "Agreement") in which it has agreed to provide ARIAD Pharmaceuticals, Inc. with up to $200 million in revenue interest financing in exchange for royalties on the net revenues of Iclusig (ponatinib).
The American Society of Plastic Surgeons today announced its strong support of the "Breast Cancer Patient Education Act" (S. 931). This bipartisan legislation is being introduced today, coinciding with National Women's Health Week, in the U.S. House of Representatives by Reps. Leonard Lance (R-NJ) and Donna Christensen, M.D. (D-VI) and in the United States Senate by Sens. Roy Blunt (R-MO), Sherrod Brown (D-OH) and David Vitter (R-LA).
"A bitter Congressional fight over the cost of superexpensive biotechnology drugs has come down to a single, hotly debated number: How many years should makers of those drugs be exempt from generic competition?" The New York Times reports.
› Verified 3 days ago
Mailing Address | Practice Location Address |
---|---|
Ashley Elizabeth Schneider, MD 14275 Midway Rd, Suite 400, Addison, TX 75001-3614 Ph: (214) 932-8029 | Ashley Elizabeth Schneider, MD 10330 Hickman Mills Dr, Kansas City, MO 64137-1618 Ph: (816) 412-7004 |
News Archive
Researchers at Children's Hospital Los Angeles have demonstrated that adolescents and young adults with congenital adrenal hyperplasia (CAH) have significantly increased amounts of abdominal fat tissue, placing them at greater risk for harmful conditions linked to obesity, including cardiovascular disease (CVD).
Initial, independent review of study data from the Selenium and Vitamin E Cancer Prevention Trial (SELECT), funded by the National Cancer Institute (NCI) and other institutes that comprise the National Institutes of Health shows that selenium and vitamin E supplements, taken either alone or together, did not prevent prostate cancer.
PDL BioPharma, Inc. today announced that it has entered into a revenue interest assignment agreement (the "Agreement") in which it has agreed to provide ARIAD Pharmaceuticals, Inc. with up to $200 million in revenue interest financing in exchange for royalties on the net revenues of Iclusig (ponatinib).
The American Society of Plastic Surgeons today announced its strong support of the "Breast Cancer Patient Education Act" (S. 931). This bipartisan legislation is being introduced today, coinciding with National Women's Health Week, in the U.S. House of Representatives by Reps. Leonard Lance (R-NJ) and Donna Christensen, M.D. (D-VI) and in the United States Senate by Sens. Roy Blunt (R-MO), Sherrod Brown (D-OH) and David Vitter (R-LA).
"A bitter Congressional fight over the cost of superexpensive biotechnology drugs has come down to a single, hotly debated number: How many years should makers of those drugs be exempt from generic competition?" The New York Times reports.
› Verified 3 days ago
Dr. Linda D Cooley, M.D. Pathology Medicare: Not Enrolled in Medicare Practice Location: 2401 Gillham Rd, Cytogenetics, Kansas City, MO 64108 Phone: 816-234-1201 Fax: 816-802-1492 | |
Dr. Alexey Glazyrin, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 2301 Holmes St, Kansas City, MO 64108 Phone: 816-404-0577 | |
Marjorie L Zucker, MD Pathology Medicare: Not Enrolled in Medicare Practice Location: 4401 Wornall, Kansas City, MO 64111 Phone: 816-932-3335 Fax: 816-932-3822 | |
Dr. Lei Shao, M.D. Pathology Medicare: Medicare Enrolled Practice Location: 2401 Gillham Rd, Pathology Department, Kansas City, MO 64108 Phone: 816-234-3234 Fax: 816-802-1492 | |
Dr. Eugenio Miguel Taboada-arana, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 2401 Gillham Rd, Pathology Department, Kansas City, MO 64108 Phone: 816-234-3234 Fax: 816-802-1492 | |
Dr. Marius Calin Tarau, M.D. Pathology Medicare: Not Enrolled in Medicare Practice Location: 950 E 21st St, Kansas City, MO 64108 Phone: 816-881-6609 Fax: 816-881-6616 | |
Mrs. Kamani M Lankachandra, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 2301 Holmes St, Kansas City, MO 64108 Phone: 816-404-0550 |